{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:56:49Z","timestamp":1794362209140,"version":"4.9.0"},"reference-count":40,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":84,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2001,9,27]]},"abstract":"<jats:sec><jats:title>Aim:<\/jats:title><jats:p>To perform a meta\u2010analysis evaluating the efficacy of H<jats:sub>2<\/jats:sub>\u2010receptor antagonists in functional (nonulcer) dyspepsia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Selection of studies:<\/jats:title><jats:p>A Medline search was used to identify placebo controlled randomized clinical trials, using the subject headings dyspepsia and H<jats:sub>2<\/jats:sub>\u2010receptor antagonist.<\/jats:p><\/jats:sec><jats:sec><jats:title>Outcome measures:<\/jats:title><jats:p>Global assessment by the patient of dyspepsia symptoms, improvement of epigastric pain and complete relief of epigastric pain.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Twenty\u2010two studies met the inclusion criteria, 15 of which reported the active drug to be superior to placebo. Many studies suffered from suboptimal study design. The odds ratio in favour of active drug was 1.48 (95% confidence interval: 0.9\u20132.3) for global assessment of dyspepsia symptoms, 2.3 (95% CI: 1.6\u20133.3) for improvement of epigastric pain, and 1.8 (95% CI: 1.2\u20132.8) for complete relief of epigastric pain.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>There is some evidence that H<jats:sub>2<\/jats:sub>\u2010receptor antagonists are superior to placebo in functional dyspepsia, but larger studies evaluating higher doses of H<jats:sub>2<\/jats:sub>\u2010receptor antagonists and of longer duration are necessary to determine the exact effect size.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2001.01044.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:45:08Z","timestamp":1047354308000},"page":"1291-1299","source":"Crossref","is-referenced-by-count":48,"title":["H<sub>2<\/sub>\u2010receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta\u2010analysis of randomized controlled clinical trials"],"prefix":"10.1111","volume":"15","author":[{"given":"H. A.","family":"Redstone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Barrowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J. O.","family":"Veldhuyzen Van Zanten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"crossref","unstructured":"NyrenO LindbergG LindstromE et\u2003al.Economic costs of functional dyspepsia. In: PharmacoEconomics. Langhorne PA: Ad is International Ltd. 1992: 312\u201324.","DOI":"10.2165\/00019053-199201050-00003"},{"key":"e_1_2_7_3_2","first-page":"145","article-title":"Functional dyspepsia: a classification with guidelines for diagnosis and management","volume":"4","author":"Talley NJ","year":"1991","journal-title":"Gastroenterol Int"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199012203232507"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529708996530"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529509101587"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529108998616"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528809093840"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00368.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309101568"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529108996251"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528809099156"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528809093874"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529208999947"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1985.tb02696.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528509089627"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198608000-00006"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529108998597"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01296918"},{"key":"e_1_2_7_22_2","first-page":"1130","article-title":"Ranitidine in the treatment of non\u2010ulcer dyspepsia. A placebo\u2010controlled study in the Federal Republic Germany","volume":"44","author":"Muller P","year":"1994","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528509089708"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198602063140603"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528609093787"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528709090977"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528509103951"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.50192000.x"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.292.6521.665"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007998909110140"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(86)90451-8"},{"key":"e_1_2_7_32_2","first-page":"980","article-title":"Symptomatic treatment of non\u2010ulcer dyspepsia with cimetidine","volume":"37","author":"DeLattre M","year":"1985","journal-title":"Curr Ther Res"},{"key":"e_1_2_7_33_2","unstructured":"LaBrooyS LovellD MisiewiczJJ.The treatment of non\u2010ulcer dyspepsia. In: Wastell C Lance P eds. Cimetidine. The Westminster Hospital Symposium. London: Churchill Livingstone 1978: 131\u201340."},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198904000-00011"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199806000-00022"},{"key":"e_1_2_7_36_2","unstructured":"PoynardT MoryB LevoirW PiguouJP NaveauS ChaputJC.Randomized clinical trials in patients with dyspepsia. In: Non\u2010ulcer Dyspepsia: Pathophysiological Therapeutic Approaches. Paris: John Libbey Eurotext 1991: 227\u201337."},{"key":"e_1_2_7_37_2","unstructured":"SooS MoayyediP DeeksJ DelaneyB InnesM FormanD.Pharmacological interventions for non\u2010ulcer dyspepsia (Cochrane Review).The Cochrane Library2001;1."},{"key":"e_1_2_7_38_2","first-page":"660","article-title":"Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials","volume":"91","author":"Veldhuyzen van Zanten SJO","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_7_39_2","first-page":"1169","article-title":"Design of treatment trials for functional gastrointestinal disorders","volume":"45","author":"Veldhuyzen van Zanten SJO","year":"1999","journal-title":"Gut"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309101568"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00410.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.01044.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.01044.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2001.01044.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T15:26:34Z","timestamp":1695828394000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2001.01044.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9,27]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,9,27]]}},"alternative-id":["10.1046\/j.1365-2036.2001.01044.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2001.01044.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9,27]]}}}